Skip to main content
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Gastroenterology
Erschienen in:

16.10.2023 | Original Article

Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis

verfasst von: Syed Ahmed, Sanchit Sharma, Samagra Agarwal, Yu Jun Wong, Martin Putera, Anoop Saraya

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

Esophageal varices (EVs), irrespective of size, are the most-reliable indicators of clinically significant portal hypertension (CSPH) in patients with compensated advanced chronic liver disease (cACLD). While non-invasive tools (NITs) accurately identify those with varices needing treatment (VNTs), their role in identifying any EVs in patients with cACLD is not known.

Methods

Patients with cACLD with reliable liver stiffness measurements (LSM), blood parameters and gastroscopy were retrospectively recruited from a multinational cohort. The performance of Baveno-VI (LSM > 20kPa and platelet count < 150,000/mm3) and expanded Baveno-VI criteria (LSM > 25kPa or platelet count < 110,000/mm3) was assessed to detect VNTs as well as any EVs. This performance was compared with the Baveno-VII possible CSPH criteria (LSM ≥ 15 kPa and platelet ≤ 150,000/mm3) to evaluate its utility in detecting any EVs.

Results

Patients with cACLD (n = 1200) of predominantly viral etiology (hepatitis B virus, 269; hepatitis C virus, 564; non-alcoholic fatty liver disease, 145; alcoholic liver disease, 130; other, 92) were included. Any EVs and VNTs were present in 514 (42.8%) and 70 (5.8%) patients, respectively. The Baveno-VI, expanded Baveno-VI and Baveno-VII criteria missed 29/514 (5.6%), 115/514 (22.4%) and 19/514 (3.7%) patients with any EVs, respectively, whereas they misclassified 517/686 (75.4%), 211/686 (30.8%) and 598/686 (87.4%) patients with no EVs as having a high risk of EVs. The Baveno-VI, expanded Baveno-VI and possible CSPH criteria missed 3/70 (4.3%), 15/70 (21.4%) and 0/70 (0%) VNTs, respectively.

Conclusion

Both original Baveno-VI and Baveno-VII criteria were highly sensitive in detecting varices in cACLD, albeit with high misclassification rates.

Graphical Abstract

Literatur
1.
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–31.CrossRefPubMed
2.
Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–8.
3.
de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–52.CrossRefPubMed
4.
Abraldes JG, Bureau C, Stefanescu H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study. Hepatology. 2016;64:2173–84.CrossRefPubMed
5.
Augustin S, Pons M, Maurice JB, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66:1980–8.
6.
Mattos ÂZ, Schacher FC, John Neto G, Mattos AA. Screening for esophageal varices in cirrhotic patients – non-invasive methods. Ann Hepatol. 2019;18:673–8.CrossRefPubMed
7.
Reiberger T. The value of liver and spleen stiffness for evaluation of portal hypertension in compensated cirrhosis. Hepatol Commun. 2021;6:950–64.CrossRefPubMedPubMedCentral
8.
Kraja B, Mone I, Akshija I, Koçollari A, Prifti S, Burazeri G. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol. 2017;23:4806–14.CrossRefPubMedPubMedCentral
9.
Payal B, MS. Ratio of platelet count to splenic diameter as a predictor of esophageal varices in cirrhosis of liver. J Assoc Physicians India. 2022;70:11–2.
10.
Jindal A, Agarwal S, Sharma S, Kumar M, Saraya A, Sarin SK. Assessment of the performance of non-invasive criteria for the evaluation of clinically significant portal hypertension in patients with compensated advanced chronic liver disease. Dig Dis Sci. 2023;68:2149–57.CrossRefPubMed
11.
Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597–608.
12.
Villanueva C, Torres F, Sarin SK, et al. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol. 2022;77:1014–25.
13.
Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Reports. 2020;2:1–17.CrossRef
14.
Huang LL, Yu XP, Li JL, et al. Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection. World J Gastroenterol. 2021;27:641–53.
15.
de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII – renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.
16.
Bae J, Sinn DH, Kang W, et al. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38:1442–8.
17.
Stafylidou M, Paschos P, Katsoula A, et al. Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1744–55.e11.
18.
Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018;69:878–85.
19.
Maurice JB, Brodkin E, Arnold F, et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol. 2016;65:899–905.
20.
Putera M, Teh KB, Kumar R, Wong YJ. Small esophageal varices in compensated cirrhosis patients: to treat or not to treat? J Hepatol. 2021;75:491–2.CrossRefPubMed
21.
Rana R, Sharma S, Ahmed S, et al. Evaluating the practice of prescribing beta-blockers in compensated cirrhosis by gastroenterologists in the Asia Pacific region. J Clin Exp Hepatol. 2023;13:380–3.
Metadaten
Titel
Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis
verfasst von
Syed Ahmed
Sanchit Sharma
Samagra Agarwal
Yu Jun Wong
Martin Putera
Anoop Saraya
Publikationsdatum
16.10.2023
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 3/2024
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01458-1

Weitere Artikel der Ausgabe 3/2024

Normative values of skeletal muscle mass, strength and performance in the Indian population

  • Original Article

Clinical profile of 1208 newly diagnosed colorectal cancer patients in Tamil Nadu—A multi-centric survey

  • Original Article

Management of collagenous gastritis in children: Case series and literature review

  • Narrative review

Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence

  • Original Article

Normative esophagogastric junction contractile integral for healthy Indian volunteers using water perfusion manometry system

  • Research letter

IgG4-related disorders of the gastrointestinal tract: Experience from a tertiary care centre with systematic review of Indian literature

  • Systematic review

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Pro & Contra: Was die Ernährungsempfehlungen der DGE bedeuten

Die Deutsche Gesellschaft für Ernährung hat kürzlich Ihre Empfehlungen aktualisiert. Was dafür spricht und was dagegen, diskutierten zwei Experten auf dem diesjährigen Kongress der Deutschen Gesellschaft für Innere Medizin.

Asthma & COPD: Pneumologische Rehabilitation zwar sinnvoll, aber zu selten umgesetzt

Für verschiedene chronische pulmonale Erkrankungen wird unter bestimmten Voraussetzungen eine pneumologische Rehabilitation empfohlen. Diese erfolgt aber nur selten. Eine ambulante Versorgung und Personal fehlen, weshalb digitale Medizin immer wichtiger wird.

GLP-1-Agonist erfolgreich gegen metabolische Fettleber

Semaglutid bringt eine metabolische Steatohepatitis bei rund zwei Dritteln der Betroffenen in Remission. Ein Drittel zeigt zudem eine geringere Fibrose. Darauf weisen Ergebnisse einer Placebo-kontrollierten Phase-3-Studie.

Was tun bei grenzwertig erhöhtem Serumkreatinin?

Ein Serumkreatinin von 1,4 mg/dl kann zwar banale extrarenale Ursachen haben, aber u. U. auch eine schwere Nierenerkrankung anzeigen. Die Urindiagnostik ist deswegen ein Muss, wie Prof. Martin Hausberg beim Kongress der DGIM darlegte.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise